NHS-PEG1-SS-PEG1-NHS

CAS No. 1688598-83-5

NHS-PEG1-SS-PEG1-NHS( —— )

Catalog No. M35095 CAS No. 1688598-83-5

NHS-PEG1-SS-PEG1-NHS is a reversible linker used for interacting biomolecules with active small molecules and is effective for linking protein liposomes or nanoparticles (NHS-PEG1-SS-PEG1-NHS).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 38 In Stock
5MG 29 In Stock
10MG 38 In Stock
25MG 49 In Stock
50MG 60 In Stock
100MG 83 In Stock
200MG 128 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NHS-PEG1-SS-PEG1-NHS
  • Note
    Research use only, not for human use.
  • Brief Description
    NHS-PEG1-SS-PEG1-NHS is a reversible linker used for interacting biomolecules with active small molecules and is effective for linking protein liposomes or nanoparticles (NHS-PEG1-SS-PEG1-NHS).
  • Description
    NHS-PEG1-SS-PEG1-NHS is a reversible linker for biomacromolecule link with active small molecule. NHS-PEG1-SS-PEG1-NHS can be used in proteins liposomes or nanoparticles.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1688598-83-5
  • Formula Weight
    436.41
  • Molecular Formula
    C14H16N2O10S2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (229.14 mM; Ultrasonic )
  • SMILES
    O=C(OCCSSCCOC(=O)ON1C(=O)CCC1=O)ON1C(=O)CCC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomas Andresen. Reversible linkers and use thereof. WO2019050977A1.
molnova catalog
related products
  • TAS1553

    TAS1553 is a highly effective, orally bioavailable protein-protein interaction (PPI) inhibitor with an IC50 value of 0.0396 μM.

  • Racemetirosine

    Racemetirosine is a Tyrosine 3-monooxygenase inhibitor, and inhibits the synthesis of catecholamines consequently.

  • Gomisin K1

    Gomisin K1 ((-)-Gomisin K1) is a lignan that exhibits anti-cancer activity. Gomisin K1 inhibits HeLa cell growth, with an IC50 of 5.46 μM.